Learn more

BONAC CORP

Overview
  • Total Patents
    191
  • GoodIP Patent Rank
    13,347
  • Filing trend
    ⇩ 18.0%
About

BONAC CORP has a total of 191 patent applications. It decreased the IP activity by 18.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are WAVE LIFE SCIENCES LTD, UNIV BONN RHEINISCHE FRIEDRICH WILHELMS and TRIPLEX PHARMA CORP.

Patent filings per year

Chart showing BONAC CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ohgi Tadaaki 112
#2 Aoki Eriko 68
#3 Hamasaki Tomohiro 67
#4 Suzuki Hiroshi 66
#5 Itoh Akihiro 56
#6 Shirohzu Hisao 44
#7 Hayashi Hirotake 40
#8 Kato Shiori 28
#9 Toyofuku Hidekazu 25
#10 Yoshida Yasuhiko 21

Latest patents

Publication Filing date Title
EP3696269A1 Single-stranded nucleic acid molecule, and production method therefor
WO2018182008A1 Cyclic nucleic acid molecule having gene expression control function
WO2018155487A1 Nucleic acid-containing powdery preparation for dpi, and use thereof
CN110198948A Novel glycoside compounds and its manufacturing method
JP2020186172A ANTI-TGF-β1 ANTIBODIES
EP3409776A1 Artificial single guide rna and use thereof
AU2016346703A1 Composition stably containing single-stranded nucleic acid molecule that suppresses expression of TGF-β1 gene
EP3301103A1 Method for producing glycoside compounds
US2018119151A1 Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability
RU2740032C2 Naturally occurring in nature sirna to control gene expression and use thereof
WO2016098782A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INHIBITING TGF-β1 EXPRESSION
US2018036409A1 Composition containing nucleic acid molecule stably
JP2017012028A ARTIFICIAL MATCH-TYPE miRNA AND APPLICATION THEREOF
MX2016008518A Artificial match-type mirna for controlling gene expression and use therefor.
WO2015099188A1 Artificial match-type mirna for controlling gene expression and use therefor
WO2015093495A1 Single-stranded nucleic acid molecule for controlling expression of tgf-β1 gene
US2015011605A1 Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
JP2015182988A EXPRESSION INHIBITOR OF NF-κB RELA GENE, PHARMACEUTICALS FOR ALLERGIC DERMATITIS AND APPLICATIONS THEREOF
US2014171486A1 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
CN104379744A Single-stranded nucleic acid molecule for regulating expression of gene having delivering function